Free Trial
LON:PXS

Provexis (PXS) Share Price, News & Analysis

GBX 0.46 -0.07 (-12.40%)
(As of 05:42 AM ET)

About Provexis Stock (LON:PXS)

Key Stats

Today's Range
0.46
0.46
50-Day Range
0.45
0.69
52-Week Range
0.41
0.90
Volume
5,476 shs
Average Volume
929,795 shs
Market Capitalization
£10.37 million
P/E Ratio
43.75
Dividend Yield
5.06%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in various foods, beverages, and dietary supplement formats. It offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and heart function. The company sells its products through distributors and online channels. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.

Receive PXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Provexis and its competitors with MarketBeat's FREE daily newsletter.

PXS Stock News Headlines

Provexis Share Chat (PXS)
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Pyxis Tankers: Bet On A Strong MR Product Tankers Market
Will Provexis (LON:PXS) Spend Its Cash Wisely?
Fenbo Holdings Ltd (FEBO)
Pyxis Tankers's Earnings: A Preview
See More Headlines

PXS Stock Analysis - Frequently Asked Questions

Provexis' stock was trading at GBX 0.65 at the beginning of the year. Since then, PXS shares have decreased by 29.4% and is now trading at GBX 0.46.
View the best growth stocks for 2024 here
.

Provexis plc (LON:PXS) announced its earnings results on Wednesday, September, 30th. The company reported ($0.02) EPS for the quarter. Provexis had a negative net margin of 73.10% and a negative trailing twelve-month return on equity of 138.67%.

Shares of PXS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Provexis investors own include Reckitt Benckiser Group (RB), Taylor Wimpey (TW), Bionano Genomics (BNGO), Bristol-Myers Squibb (BMY), Bumble (BMBL), BEST (BEST) and Alibaba Group (BABA).

Company Calendar

Last Earnings
9/30/2020
Today
11/21/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Transportation
CIK
N/A
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£426,168.00

Miscellaneous

Outstanding Shares
2,260,000,000
Free Float
N/A
Market Cap
£10.37 million
Optionable
Not Optionable
Beta
1.21
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

This page (LON:PXS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners